Cramer's Lightning Round - Agilent Is Sensational (1/28/14)

 |  Includes: A, ACAD, ARNA, AWR, BMY, LINEQ, PFE, SD, WIN
by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday January 28.

Bullish Calls:

Agilent Technologies (NYSE:A): "We've got to buy it. They are splitting up the company. It is really sensational."

Pfizer (NYSE:PFE), Bristol Myers (NYSE:BMY): "I've got Pfizer reporting a good number. I've got BMY down a lot, and it reported a good number. You want to pull the trigger."

Acadia Pharmaceuticals (NASDAQ:ACAD): "Behavioral and psychiatric. We need those in this country. That is a really interesting stock."

SandRidge (NYSE:SD), Linn Energy (LINE): "I remain on board SandRidge. Linn has a 9% yield and it is filled with natural gas."

American States Water (NYSE:AWR): "It has a high yield and a good chart. I like the business."

Bearish Calls:

Arena Pharmaceutical (NASDAQ:ARNA): Cramer prefers Bristol Myers and Pfizer.

Windstream (NASDAQ:WIN): "I wasn't happy with that quarter or the one before that. This company is going to be challenged to maintain its yield, so I'm going to say 'sell.'"


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.